CIDRAP newsletters options
Research suggests exposure to fungicides is promoting resistance in Aspergillus fumigatis.
Researchers detail new findings on long COVID risk, plus a promising role for occupational therapy to help cope with symptoms.
With deaths at the lowest point in about 2 years and cases declining, the WHO urged countries to keep a close eye on cases and virus changes.
Following the reappearance of Ebola in the Democratic Republic of the Congo's (DRC's) Equateur province, the country today launched an rVSV-EBOV vaccine campaign, tapping an initial shipment of 200 doses, the World Health Organization (WHO) African regional office said today.
The roadmap "will provide a framework for the development of broadly protective coronavirus vaccines to ensure that we are prepared to respond" to future SARS-CoV-2 variants or other viruses with pandemic potential.
Also, federal officials are taking steps to make sure Pfizer's COVID-19 pill, Paxlovid, will be widely available across the US.
Two thirds of family members restricted from visiting loved ones in the ICU had symptoms of PTSD 3 months later.
Sepsis remains a leading cause of death in young children, with 20 million global cases and 2.9 million deaths.
Israelis aged 60 and older given a fourth dose of the Pfizer/BioNTech COVID-19 vaccine amid the Omicron surge had a 64% lower risk of hospitalization and 78% lower risk of death than those who received three doses, suggests an observational study published yesterday in Nature Medicine.
The Democratic Republic of the Congo (DRC) has confirmed a second case in its latest Ebola outbreak in Equateur province, a close contact of the index patient. The newest patient has also died from her infection.
The virus has claimed the life of a 31-year-old man in Equateur province.
US cases, now nearing 50,000 per day, are rising fastest in the Midwest and Northeast.
Data show a 36% to 68% lower risk of a COVID-19 hospital stay with Omicron.
A modeling study estimates that COVID-19 vaccination prevented more than 1.5 million infections, 72,000 hospitalizations, and 19,000 deaths in the first 10 months of vaccination in California, according to a study published late last week in JAMA Network Open.
Patients hospitalized during the COVID-19 pandemic and tested for SARS-CoV-2 had higher rates of antibiotic-resistant infections compared with those hospitalized before the pandemic, according to a study presented yesterday at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022).
Extending the time between COVID-19 vaccine doses to over 10 weeks was tied to 11 times higher antibody levels.
"Policy makers should be largely reassured by people's aggregate capacity to cope."
Only heart disease and cancer killed more Americans than COVID-19, and COVID deaths increased by 1% in 2021 over 2020.
A third mRNA dose boosts the immune system to better fight Omicron infections, 2 studies find.
Also, the WHO revised its assessment of remdesivir, recommending it for mild or moderate infections in high-risk groups.